((S)-1-(tert-butoxycarbonyl)azetidin-2-yl)methyl 4-methylbenzenesulfonate | 209328-53-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ((S)-1-(tert-butoxycarbonyl)azetidin-2-yl)methyl 4-methylbenzenesulfonate
• 英文别名: 1-(tert-butoxycarbonyl)-2(S)-[(4-toluenesulfonyloxy)methyl]azetidine；(S)-tert-butyl 2-(tosyloxymethyl)azetidine-1-carboxylate；tert-butyl (2S)-2-({[(4-methylphenyl)sulfonyl]oxy}methyl)azetidine-1-carboxylate；(S)-2-(Toluene-4-sulfonyloxymethyl)azetidinecarboxylic acid tert-butyl ester；((S)-1-(tert-butoxycarbonyl)azetidine-2-yl)methyl 4-methylbenzenesulfonate；(S)-tert-Butyl 2-((tosyloxy)methyl)azetidine-1-carboxylate；tert-butyl (2S)-2-[(4-methylphenyl)sulfonyloxymethyl]azetidine-1-carboxylate
• CAS: 209328-53-0
• 化学式: C₁₆H₂₃NO₅S
• 分子量: 341.428
• InChiKey: GHOGMHPEFWQXQZ-ZDUSSCGKSA-N

物化性质

• 沸点：
  461.2±18.0 °C(Predicted)
• 密度：
  1.223±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  81.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  ((S)-1-(tert-butoxycarbonyl)azetidin-2-yl)methyl 4-methylbenzenesulfonate 在 氢氧化钾 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 3-(1-t-butyloxycarbonyl-(2S)-azetidinylmethoxy)-6-chloropyridine
  参考文献：
  名称：

  3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission

  摘要：

  新型3-吡啶氧甲基杂环醚化合物的化学式为： 或其药学上可接受的盐或前药是神经元胆碱能受体选择性和有效的配体，并且在控制突触传递方面具有良好效果。还描述了使用这些关键中间体的关键中间体和过程，以生产具有规范中定义的变量的化合物I的方法。

  公开号：

  US06437138B1
• 作为产物：
  描述：

  1-Boc-L-吖啶-2-羧酸 在 吡啶 、 硼烷 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 48.0h， 生成 ((S)-1-(tert-butoxycarbonyl)azetidin-2-yl)methyl 4-methylbenzenesulfonate
  参考文献：
  名称：

  N-Benzylisatin Sulfonamide Analogues as Potent Caspase-3 Inhibitors:  Synthesis, in Vitro Activity, and Molecular Modeling Studies

  摘要：

  A number of isatin sulfonamide analogues were prepared and their potencies for inhibiting caspase-1, -3, -6, -7, and -8 were evaluated in vitro. Several compounds displaying a nanomolar potency for inhibiting the executioner caspases, caspase-3 and caspase-7, were identified. These compounds were also observed to have a low potency for inhibiting the initiator caspases, caspase-1 and caspase-8, and caspase-6. Molecular modeling studies provided further insight into the interaction of this class of compounds with activated caspase-3. The results of the current study revealed a number of non-peptide-based caspase inhibitors that may be useful in assessing the role of inhibiting the executioner caspases in minimizing tissue damage in disease conditions characterized by unregulated apoptosis.

  DOI：

  10.1021/jm0506625

文献信息

• NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF
  申请人：Chandrasekhar Jayaraman

  公开号：US20130184313A1

  公开（公告）日：2013-07-18

  The invention relates to pyridinyl nicotinic acetylcholine receptor ligands, compositions comprising an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand and methods to treat or prevent a condition, such as depression and nicotine dependence, comprising administering to an animal in need thereof an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand.

  该发明涉及吡啶基烟碱乙酰胆碱受体配体，包含有效量吡啶基烟碱乙酰胆碱受体配体的组合物，以及治疗或预防某种疾病的方法，如抑郁症和尼古丁依赖症，包括向需要的动物施用有效量吡啶基烟碱乙酰胆碱受体配体。
• 3-Pyridyl enantiomers and their use as analgesics
  申请人：Abbott Laboratories

  公开号：US06133253A1

  公开（公告）日：2000-10-17

  The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula I: ##STR1## or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula I above which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.

  本发明涉及一种控制哺乳动物（包括人类）疼痛的方法，包括向需要治疗的哺乳动物或患者施用公式I所选化合物：##STR1##或其药学上可接受的盐。该发明还涉及上述公式I的选定(R)和(S)化合物，其可用作镇痛剂、神经细胞凋亡抑制剂和抗炎药。
• ISATIN ANALOGUES AND USES THEREFOR
  申请人：Mach Robert H.

  公开号：US20090068105A1

  公开（公告）日：2009-03-12

  Novel isatin analogues, including isatin analogues comprising Michael Acceptors (IMAs) are disclosed. Further disclosed are methods of synthesis of the isatin analogues, and uses of the analogues, including inhibition of caspase-3 and caspase-7, and in vivo imaging of apoptosis by Positron emission tomography (PET) or Single Photon Emission Computed Tomography (SPECT).

  揭示了新颖的吲哚类似物，包括具有Michael受体的吲哚类似物（IMAs）。进一步揭示了吲哚类似物的合成方法，以及类似物的用途，包括抑制caspase-3和caspase-7，以及通过正电子发射断层扫描（PET）或单光子发射计算机断层扫描（SPECT）对凋亡进行体内成像。
• TAXANE COMPOUND WITH AZETIDINE RING STRUCTURE
  申请人：Daiichi Sankyo Company, Limited

  公开号：EP1942109A1

  公开（公告）日：2008-07-09

  A compound represented by the general formula (1) [X1 and X2 represent hydrogen atom, a halogen atom, hydroxyl group and the like, R1 represents a phenyl group, R2 represents an alkyl group, an alkenyl group, or an alkoxy group, R3 represents hydrogen atom, a halogen atom, hydroxyl group, or an alkoxy group, R4 represents hydrogen atom, or an alkyl group, Z1 and Z2 represent hydrogen atom, a halogen atom, hydroxyl group and the like, Z3 represents cyano group, an alkyl group, an alkenyl group and the like, Z4 represents an alkyl group, an alkenyl group, an alkynyl group and the like, and ---- represents a single bond or a double bond], which shows high antitumor effect against cancer cells including drug resistant cells.

  一个由通式（1）表示的化合物，其中[X1和X2代表氢原子，卤素原子，羟基等，R1代表苯基，R2代表烷基，烯基或烷氧基，R3代表氢原子，卤素原子，羟基或烷氧基，R4代表氢原子或烷基，Z1和Z2代表氢原子，卤素原子，羟基等，Z3代表氰基，烷基，烯基等，Z4代表烷基，烯基，炔基等，----代表单键或双键]，对包括药物耐药细胞在内的癌细胞表现出高抗肿瘤效果。
• Imidazothiazole derivatives
  申请人：Kawato Haruko

  公开号：US20090312310A1

  公开（公告）日：2009-12-17

  There is provided a novel compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. The present invention provides an imidazothiazole derivative represented by the following formula (1) having various substituents that inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity: wherein R 1 , R 2 , R 3 , R 4 , and R 5 in the formula (1) each has the same meaning as defined in the specification.

  提供了一种新的化合物，它抑制小鼠双分子分钟2（Mdm2）蛋白与p53蛋白之间的相互作用，并展现出抗肿瘤活性。本发明提供了一种咪唑噻唑衍生物，其表示为以下公式（1），具有各种取代基，可抑制Mdm2蛋白与p53蛋白之间的相互作用并展现出抗肿瘤活性：其中，公式（1）中的R1、R2、R3、R4和R5每个都具有规范中定义的相同含义。